18.5Fr resector
Showing 1 - 25 of 2,900
Rate of Complete Resection in a Unique Surgical Time Trial in Le Kremlin-Bicêtre (18.5 resector, 26Fr resector)
Recruiting
- Rate of Complete Resection in a Unique Surgical Time
- 18.5 resector
- 26Fr resector
-
Le Kremlin-Bicêtre, FranceHopital Bicetre
Jan 26, 2021
Overactive Bladder (OAB), Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron, Placebo)
Recruiting
- Overactive Bladder (OAB)
- Pharmacokinetics of Mirabegron
- Mirabegron
- Placebo
-
Edegem, Belgium
- +34 more
Nov 28, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Efgartigimod IV)
Recruiting
- Generalized Myasthenia Gravis
- Efgartigimod IV
-
Wien, Austria
- +12 more
Jul 19, 2022
Multifocal Motor Neuropathy Trial in Worldwide (ARGX-117, Placebo)
Recruiting
- Multifocal Motor Neuropathy
- ARGX-117
- Placebo
-
Scottsdale, Arizona
- +33 more
Dec 20, 2022
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric
Active, not recruiting
- Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
- +3 more
- zolbetuximab
- +4 more
-
Phoenix, Arizona
- +219 more
Aug 16, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- prednisone
-
Birmingham, Alabama
- +120 more
Dec 22, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
Urinary Bladder Tumors Trial in Worldwide (drug, other, biological)
Active, not recruiting
- Urinary Bladder Neoplasms
- nivolumab
- +2 more
-
Aurora, Colorado
- +102 more
Nov 16, 2022
NSCLC, Tumor Metastasis Trial in L'Hospitalet De Llobregat (34 Gy in a single fraction, 54Gy 18Gy/fr. x 3 fractions, 60Gy (12 x
Unknown status
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
- 34 Gy in a single fraction
- +3 more
-
L'Hospitalet De Llobregat, Barcelona, SpainInstitut Català d'Oncologia - L'Hospitalet
Aug 6, 2019
Miscarriage Trial in France (hysteroscopy, Aspiration)
Not yet recruiting
- Miscarriage
- hysteroscopy
- Aspiration
-
Bordeaux, France
- +3 more
Mar 30, 2023
Breast Cancer Trial in Worldwide (trastuzumab, docetaxel, lapatinib ditosylate)
Active, not recruiting
- Breast Cancer
- trastuzumab
- +3 more
-
Anchorage, Alaska
- +257 more
Feb 28, 2022
Stroke, Acute, Atrial Fibrillation Trial in United Kingdom (Direct oral anticoagulant (DOAC))
Recruiting
- Stroke, Acute
- Atrial Fibrillation
- Direct oral anticoagulant (DOAC)
-
Aberystwyth, United Kingdom
- +43 more
Nov 6, 2020
Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- Plasma ctDNA
- FFPE blocks
-
Angers, France
- +35 more
Sep 19, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Kidney Calculi Trial in Istanbul (Flexible Ureterorenoscopy, Mini Percutaneous Nephrolithotomy)
Completed
- Kidney Calculi
- Flexible Ureterorenoscopy
- Mini Percutaneous Nephrolithotomy
-
Istanbul, Sultangazi, TurkeyHaseki Training and Research Hospital
Jun 21, 2023
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023
Electromagnetic Radiation (5GFR2) Trial (5GFR2 non ionizing EMW exposure)
Not yet recruiting
- Electromagnetic Radiation (5GFR2)
- 5GFR2 non ionizing EMW exposure
- (no location specified)
Jun 28, 2023
Turkish Adaptation Of GMFCS Family Report And The Agreement Of
Completed
- Cerebral Palsy
- GMFCS-FR Turkish Adaptation
-
Ankara, TurkeyHacettepe University Faculty of Physical Therapy and Rehabilitat
Apr 4, 2023
CAROTID STENOSIS Trial in Bron ([18F]DPA-714 PET)
Not yet recruiting
- CAROTID STENOSIS
- [18F]DPA-714 PET
-
Bron, FranceService de Neurologie vasculaire / CarMeN U1060 INSERM Hôpital N
May 11, 2023
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Tinnitus and Hearing Loss in Locally Advanced Head and Neck
Not yet recruiting
- Head Cancer
- Neck Cancer
-
Paris, FranceRadiotherapy Oncology Service TENON Hospital
Jul 7, 2023
Ankle Trauma in Children, Application of Ottawa Ankle Rules From
Recruiting
- Sports Injuries in Children
- OTTAWA ANKLE RULES
-
Vandoeuvre Les Nancy, Meurthe-et-Moselle, Francechildren hospital Nancy
Jun 16, 2023
Urinary Catheters, Urinary Tract Infection Trial in Dalian (disposable urinary catheter, super smooth antibacterial urinary
Completed
- Urinary Catheters
- Urinary Tract Infection
- disposable urinary catheter
- super smooth antibacterial urinary catheter
-
Dalian, Liaoning, ChinaLiaoning Cancer Hospital & institute
Dec 12, 2022
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023